• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种预测化学感应受体新型配体的两阶段计算方法。

A two-stage computational approach to predict novel ligands for a chemosensory receptor.

作者信息

Jabeen Amara, Vijayram Ramya, Ranganathan Shoba

机构信息

Department of Molecular Sciences, Macquarie University, Sydney, NSW 2109, Australia.

Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600036, Tamilnadu, India.

出版信息

Curr Res Struct Biol. 2020 Oct 9;2:213-221. doi: 10.1016/j.crstbi.2020.10.001. eCollection 2020.

DOI:10.1016/j.crstbi.2020.10.001
PMID:34235481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8244491/
Abstract

Olfactory receptor (OR) 1A2 is the member of largest superfamily of G protein-coupled receptors (GPCRs). OR1A2 is an ectopically expressed receptor with only 13 known ligands, implicated in reducing hepatocellular carcinoma progression, with enormous therapeutic potential. We have developed a two-stage screening approach to identify novel putative ligands of OR1A2. We first used a pharmacophore model based on atomic property field (APF) to virtually screen a library of 5942 human metabolites. We then carried out structure-based virtual screening (SBVS) for predicting the potential agonists, based on a 3D homology model of OR1A2. This model was developed using a biophysical approach for template selection, based on multiple parameters including hydrophobicity correspondence, applied to the complete set of available GPCR structures to pick the most appropriate template. Finally, the membrane-embedded 3D model was refined by molecular dynamics (MD) simulations in both the and forms. The refined model in the form was selected for SBVS. Four novel small molecules were identified as strong binders to this olfactory receptor on the basis of computed binding energies.

摘要

嗅觉受体(OR)1A2是G蛋白偶联受体(GPCR)最大超家族的成员。OR1A2是一种异位表达的受体,仅有13种已知配体,与降低肝细胞癌进展有关,具有巨大的治疗潜力。我们开发了一种两阶段筛选方法来鉴定OR1A2的新型假定配体。我们首先使用基于原子性质场(APF)的药效团模型对5942种人类代谢物库进行虚拟筛选。然后,基于OR1A2的三维同源模型进行基于结构的虚拟筛选(SBVS)以预测潜在激动剂。该模型是使用生物物理方法进行模板选择开发的,基于包括疏水性对应在内的多个参数,应用于整套可用的GPCR结构以选择最合适的模板。最后,通过分子动力学(MD)模拟在α和β形式下对膜嵌入的三维模型进行优化。选择α形式的优化模型进行SBVS。基于计算出的结合能,鉴定出四种新型小分子为该嗅觉受体的强结合剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8120/8244491/7e3a15413cdb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8120/8244491/867df931991a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8120/8244491/2bb8e12f66cd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8120/8244491/8a0dd54d8f44/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8120/8244491/afa6033eaed1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8120/8244491/7e3a15413cdb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8120/8244491/867df931991a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8120/8244491/2bb8e12f66cd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8120/8244491/8a0dd54d8f44/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8120/8244491/afa6033eaed1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8120/8244491/7e3a15413cdb/gr4.jpg

相似文献

1
A two-stage computational approach to predict novel ligands for a chemosensory receptor.一种预测化学感应受体新型配体的两阶段计算方法。
Curr Res Struct Biol. 2020 Oct 9;2:213-221. doi: 10.1016/j.crstbi.2020.10.001. eCollection 2020.
2
A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics.一种用于发现 5-羟色胺 2A 拮抗剂的新型鉴定方法:二维/三维相似性筛选、分子对接和分子动力学的组合。
J Biomol Struct Dyn. 2019 Mar;37(4):931-943. doi: 10.1080/07391102.2018.1444509. Epub 2018 Mar 5.
3
Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.基于配体和结构的计算机模拟研究鉴定驱动蛋白纺锤体蛋白 (KSP) 抑制剂作为潜在的抗癌药物。
J Biomol Struct Dyn. 2018 Nov;36(14):3687-3704. doi: 10.1080/07391102.2017.1396255. Epub 2017 Nov 29.
4
Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.基于药效团的结构见解,通过计算机辅助筛选,鉴定人源 Toll 样受体 4-髓样分化因子 2(hTLR4-MD-2)复合物抑制剂。
J Biomol Struct Dyn. 2019 May;37(8):1968-1991. doi: 10.1080/07391102.2018.1474804. Epub 2018 May 29.
5
Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.基于对接的虚拟筛选技术用于 G 蛋白偶联受体配体的可靠性研究:以血管紧张素 II 型 1 型受体为例。
ACS Chem Neurosci. 2019 Jan 16;10(1):677-689. doi: 10.1021/acschemneuro.8b00489. Epub 2018 Oct 17.
6
Ligand-Binding-Site Refinement to Generate Reliable Holo Protein Structure Conformations from Apo Structures.配体结合部位精修以从 apo 结构生成可靠的全蛋白结构构象。
J Chem Inf Model. 2021 Jan 25;61(1):535-546. doi: 10.1021/acs.jcim.0c01354. Epub 2020 Dec 18.
7
Introducing a simple model system for binding studies of known and novel inhibitors of AMPK: a therapeutic target for prostate cancer.引入一个简单的模型系统,用于研究已知和新型 AMPK 抑制剂的结合:一种治疗前列腺癌的治疗靶点。
J Biomol Struct Dyn. 2019 Feb;37(3):781-795. doi: 10.1080/07391102.2018.1441069. Epub 2018 Feb 23.
8
Extended template-based modeling and evaluation method using consensus of binding mode of GPCRs for virtual screening.基于模板的扩展建模和评估方法,利用 GPCR 结合模式的共识进行虚拟筛选。
J Chem Inf Model. 2014 Nov 24;54(11):3153-61. doi: 10.1021/ci500499j. Epub 2014 Nov 11.
9
Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.通过基于药效团的设计、3D-QSAR 和针对阿尔茨海默病的分子动力学模拟来鉴定潜在的蛋白激酶 C 抑制剂。
J Biomol Struct Dyn. 2018 Nov;36(15):4029-4044. doi: 10.1080/07391102.2017.1406824. Epub 2017 Dec 13.
10
Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.基于药效团模型的 Wee1 激酶抑制剂的多位点对接和分子动力学研究。
J Biomol Struct Dyn. 2019 Jul;37(10):2703-2715. doi: 10.1080/07391102.2018.1495576. Epub 2018 Dec 24.

引用本文的文献

1
Chemosensory Receptors in Vertebrates: Structure and Computational Modeling Insights.脊椎动物的化学感受器:结构与计算建模见解
Int J Mol Sci. 2025 Jul 10;26(14):6605. doi: 10.3390/ijms26146605.
2
Template-based modeling of insect odorant receptors outperforms AlphaFold3 for ligand binding predictions.基于模板的昆虫气味受体建模在配体结合预测方面优于 AlphaFold3。
Sci Rep. 2024 Nov 23;14(1):29084. doi: 10.1038/s41598-024-80094-x.
3
Transformation of peptides to small molecules in medicinal chemistry: Challenges and opportunities.

本文引用的文献

1
Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore , improves telogen effluvium-associated parameters.局部应用特定嗅觉受体OR2AT4激动剂檀香醇可改善休止期脱发相关指标。
J Cosmet Dermatol. 2021 Mar;20(3):784-791. doi: 10.1111/jocd.13608. Epub 2020 Jul 29.
2
Common activation mechanism of class A GPCRs.A 类 G 蛋白偶联受体的共同激活机制。
Elife. 2019 Dec 19;8:e50279. doi: 10.7554/eLife.50279.
3
Understanding Ligand Binding to G-Protein Coupled Receptors Using Multiscale Simulations.利用多尺度模拟理解配体与G蛋白偶联受体的结合
药物化学中肽向小分子的转化:挑战与机遇
Acta Pharm Sin B. 2024 Oct;14(10):4243-4265. doi: 10.1016/j.apsb.2024.06.019. Epub 2024 Jun 25.
4
An overview on olfaction in the biological, analytical, computational, and machine learning fields.生物学、分析学、计算科学及机器学习领域中的嗅觉综述。
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400414. doi: 10.1002/ardp.202400414. Epub 2024 Oct 22.
5
Mind the Gap-Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence.关注差距——利用三维药效团和人工智能解析GPCR药理学
Pharmaceuticals (Basel). 2022 Oct 22;15(11):1304. doi: 10.3390/ph15111304.
6
BIO-GATS: A Tool for Automated GPCR Template Selection Through a Biophysical Approach for Homology Modeling.生物GATS:一种通过生物物理方法进行同源建模自动选择GPCR模板的工具。
Front Mol Biosci. 2021 Apr 7;8:617176. doi: 10.3389/fmolb.2021.617176. eCollection 2021.
Front Mol Biosci. 2019 May 3;6:29. doi: 10.3389/fmolb.2019.00029. eCollection 2019.
4
Applications of machine learning in GPCR bioactive ligand discovery.机器学习在 G 蛋白偶联受体生物活性配体发现中的应用。
Curr Opin Struct Biol. 2019 Apr;55:66-76. doi: 10.1016/j.sbi.2019.03.022. Epub 2019 Apr 18.
5
OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism.OR14I1 是人类巨细胞病毒五聚体复合物的受体,决定了病毒的上皮细胞嗜性。
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7043-7052. doi: 10.1073/pnas.1814850116. Epub 2019 Mar 20.
6
New Binding Sites, New Opportunities for GPCR Drug Discovery.新结合位点,GPCR 药物发现的新机遇。
Trends Biochem Sci. 2019 Apr;44(4):312-330. doi: 10.1016/j.tibs.2018.11.011. Epub 2019 Jan 3.
7
Olfactory, Taste, and Photo Sensory Receptors in Non-sensory Organs: It Just Makes Sense.非感觉器官中的嗅觉、味觉和光感受器:这很有道理。
Front Physiol. 2018 Nov 27;9:1673. doi: 10.3389/fphys.2018.01673. eCollection 2018.
8
Therapeutic potential of ectopic olfactory and taste receptors.异位嗅觉和味觉受体的治疗潜力。
Nat Rev Drug Discov. 2019 Feb;18(2):116-138. doi: 10.1038/s41573-018-0002-3.
9
GPCR homology model template selection benchmarking: Global versus local similarity measures.GPCR 同源模型模板选择基准测试:全局与局部相似性度量。
J Mol Graph Model. 2019 Jan;86:235-246. doi: 10.1016/j.jmgm.2018.10.016. Epub 2018 Oct 21.
10
[Comparison of effects of oleic acid and palmitic acid on lipid deposition and mTOR / S6K1 / SREBP-1c pathway in HepG2 cells].[油酸和棕榈酸对HepG2细胞脂质沉积及mTOR/S6K1/SREBP-1c通路影响的比较]
Zhonghua Gan Zang Bing Za Zhi. 2018 Jun 20;26(6):451-456. doi: 10.3760/cma.j.issn.1007-3418.2018.06.012.